PTE

PolarityTE Inc

Healthcare


Presented:06/06/2018
Price:$29.92
Cap:$0.62B
Current Price:$0.11
Cap:$0.00B

Presented

Date06/06/2018
Price$29.92
Market Cap$0.62B
Ent Value$0.25B
P/E RatioN/A
Book ValueN/A
Div Yield0%
Shares O/S20.75M
Ave Daily Vol347,647
Short Int34.19%

Current

Price$0.11
Market Cap$0.00B
PolarityTE, Inc. engages in the regenerative medicine and tissue engineering platform. The firm seeks to develop and obtain regulatory approval for technology that will utilize a patient's own tissue substrates for the regeneration of skin, bone, muscle, cartilage, fat, blood vessels and nerves. Its products include SkinTE, OsteoTE, AngioTE, MyoTE, CartTe, AdiposeTE, and NeuralTE. The company was founded in 2004 and is headquartered in Salt Lake City, UT.

Publicly traded companies mentioned herein: Allergan plc (AGN), Integra Lifesciences Holdings Corp (IART), MiMedix Group Inc (MDXG), PolarityTE Inc (COOL)

Highlights

The presenter is long PolarityTE (COOL), which began trading in 2017 as a result of a reverse merger with former gaming company Majesco Entertainment. While there are a number of controversial investors/people involved in PolarityTE as a result of the reverse merger, the company appears to be building an extremely promising regenerative medicine platform. CEO Denver Lough is “one of the smartest people” the presenter has ever met, and a number of the key executives - including Lough himself - left promising careers to build the company. It is difficult to gauge the potential upside, and an investment in COOL is definitely not without risk, but the burn/ skin graft market alone is estimated to be worth upwards of $20B - $30B, making the risk/reward highly attractive long-term if management can execute.

  • Signing up and creating account with us unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

  • Signing up and creating account with us unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Request access to DeMatteo Research for full access

Request Access

Already have an account?

Idea Discussion

Commentor 1 - 2 weeks ago

Signing up and creating account with us, unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Commentor 1 - 2 weeks ago

Signing up and creating account with us, unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Idea Discussions display submitted commentary from our investor community.

To read and participate in the discussion with the presenter and investor base, request access to DeMatteo

Request Access

Already have an account?

An error occurred loading this content. Try again later or contact us.